The Seventh International Conference on Cell Therapy for Cardiovascular Disease sponsored by the Cardiovascular Research Foundation (CRF) is a comprehensive program dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke. This year's conference will focus on preclinical and clinical studies on the path to commercialization, highlighting the status of molecular, cell, and tissue products in addition to delivery systems.
Noteworthy presentations include a potential role for cell therapy in metabolic syndrome, large-scale studies in patients with heart failure and ST segment elevation myocardial infarction (STEMI) and early phase studies with new biologics involving endometrial cells.
The latest conference agenda is available at http://celltherapy.
Now in its 11th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has seen many notable successes, as well as identified challenges that await the next round of clinical studies. Leaders in the field will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies.
In addition, Friday's sessions will focus on developing a rational policy towards stem cell study and utilization. Leading experts will also discuss the benefits and drawbacks of stem cell tourism.
Warren Sherman, MD
New York-Presbyterian Hospital/Columbia University Medical Center
New York, NY
Josef Bartunek, MD, PhD
Cardiovascular Center, OLV Hospital
Henricus J. Duckers, MD, PhD
Erasmus University Hospital
Amit Patel, MD, MS
University of Utah
Salt Lake City, Utah
Marc S. Penn, MD, PhD
Summa Health System
January 25-27, 2012
Vivian and Seymour Milstein Family Heart Center
Myrna L. Daniels Auditorium
NYPH/Columbia University Medical Center
173 Fort Washington Avenue, 1st Floor
New York, NY 10032
For more information visit:
HOW TO REGISTER:
Media may apply for registration by visiting http://celltherapy.
The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies, drugs, and therapies in the subspecialty of interventional cardiology and endovascular medicine. For more information visit: http://www.